Silk protein-based medical devices startup Fibroheal Woundcare has raised ₹6.3 crore in its pre-Series A funding round, attracting support from its existing promoters and a new group of investors, including surgeons, medical professionals, and bankers.
The company has also received commitments for an additional ₹10 crore from current and new backers.
The funding will be used to strengthen Fibroheal’s go-to-market strategy, expand its workforce, and further develop its product pipeline within the medical devices segment, according to a company statement.
About Fibroheal Woundcare:
Founded in April 2017 by Vivek Mishra and Bharat Tandon, with S Subramanian joining in 2018 as a co-promoter, Fibroheal’s products are currently used in over 500 hospitals across 19 states in India. The startup has also expanded into online sales via e-commerce platforms.
As an R&D-focused startup, Fibroheal has 8 granted patents and others under review. The company collaborates with leading institutions like IISc Bangalore under the PMRF program. One key outcome of this collaboration is Fibroplug, an external hemostatic product that has successfully treated over 3,000 bleeding cases within four months of its launch.
Also Read:
EV Startup VOICE Raises INR 5 Crore in Seed Funding
Fibroheal’s product lineup includes foams, mesh, and powders aimed at treating a variety of wounds, including acute, chronic, traumatic, post-operative, and non-healing wounds like bedsores or infected surgical wounds.
This funding round also saw participation from Dr. KK Narayanan, the co-founder of Metahelix Life Sciences, which was acquired by Rallis India, and Kottaram Agrofoods (Soulfull Cereals), later acquired by Tata Consumer Products. Highlighting Fibroheal’s potential, Dr. Narayanan stated, “Woundcare is a fast-growing segment of the health and wellness sector. Fibroheal is poised to become a major player in this sector with a differentiated technology based on natural silk, committed leadership, and a competent team.”
The startup had previously raised funding from Telama Investments, CCAMP, and KITVEN.
